WebFounder - CEO at Sideris Pet Pharmaceuticals CEO at Select Software & Business Solutions S.A. CEO at Eurosoft S.A. Greece. Sideris Pet Pharmaceuticals, +5 more. University of Houston, +1 more. WebOct 23, 2013 · Sideris Pharmaceuticals Completes $32 Million Equity Financing and Signs Agreement With Global Pharmaceutical Company BOSTON & GAINESVILLE, Fla.--(BUSINESS WIRE)--Sideris Pharmaceuticals, Inc., announced today that it has successfully completed a $32 million Series A equity financing.
Did you know?
WebApr 7, 2024 · Sideris Pharmaceuticals has raised a total funding of $49.6M over 3 rounds. Their latest funding round was a Series A round on Oct 24, 2013 for $17M. View Sideris Pharmaceuticals Funding Rounds or take a look at Sideris Pharmaceuticals Investors WebOct 23, 2013 · Sideris Pharmaceuticals has entered into an agreement with Novartis Pharmaceuticals whereby Novartis has been granted an exclusive right to acquire Sideris and its lead asset, the iron-chelating candidate SP-420. Including upfront, acquisition and milestone payments, the agreement with Novartis could reach up to $300 million. Sideris …
WebSideris Unknown n/a Sideris Pharmaceuticals, Inc. is an independent biopharmaceutical company developing treatments for diseases of iron overload, including conditions involving maintenance transfusion therapy. Sideris’ lead clinical candidate, SP-420, has the potential to be the best-in-class therapeutic approach as an oral iron chelator. WebSP-420 is covered by an issued patent that has been exclusively licensed to Sideris. Sideris Pharmaceuticals Inc. is a privately held biopharmaceutical company focused on the development of therapeutics for the treatment of transfusion-related iron overload. The company’s operations include facilities in Boston, MA, and in Gainesville, FL.
WebCompany profile page for Sideris Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information WebOct 26, 2013 · Sideris Pharmaceuticals spun out earlier this year with a license from the University of Florida on research indicating how to reduce a body’s iron levels. Novartis has the right to acquire this potential treatment, SP-420, in a …
WebJun 6, 2024 · Jun. 6, 2024, 08:00 AM. CAMBRIDGE, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products to treat cancer and infectious ...
WebSideris Unknown n/a Sideris Pharmaceuticals, Inc. is an independent biopharmaceutical company developing treatments for diseases of iron overload, including conditions involving maintenance transfusion therapy. Sideris’ lead clinical candidate, SP-420, has the potential to be the best-in-class therapeutic approach as an oral iron chelator. high altitude in peruWebHe has 30+ years of experience and has served as President of R&D and CMO of GT Biopharma, CMO of Celularity, executive roles at Verastem, Sideris Pharmaceuticals, BIND Therapeutics, Abraxis BioScience, Intellikine, and served on the integration leadership team during the Celgene acquisition of Abraxis in 2010. high altitude hypoxia icd 10WebSP 420 is a brain-penetrant iron chelator, being developed by Abfero Pharmaceuticals (a subsidiary of Pharmacosmos), under a license from University of Florida, SP 420 ... Developer Sideris Pharmaceuticals Class Small molecules Mechanism of Action Iron chelating agents Orphan Drug Status ... how far is greensboro from charlotteWebJun 6, 2024 · CAMBRIDGE, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products to treat... high altitude in tagalogWebMar 10, 2024 · Allorion Therapeutics, a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, announces the completion of a $50 million Series B financing round, co-led by INCE Capital and Qiming Venture Partners, with participation from TF Capital, Long River Investment (LRI), 3SBio, Octagon Capital, … high altitude ii packageWebAbout Sideris Pharmaceuticals. Manufacturer / Exporter / Supplier / Retailer Of Dexedrine Pills, Pain Relief Drugs, Pain Relief Tablet, Pharmaceutical Drugs, Pharmaceutical Injection, pharmaceutical pain relief drugs, Pharmaceutical Tablets, Steroids, Drugs, Pain Killer Oil, Pain Killer, Zepose Tablets, Oxymetholone Ih 50 Mg Tablets, Demerol Tablets, Etizest … high altitude illnessWebThe Medicines Co. (NASDAQ:MDCO) Atlas Venture Neurology Single asset $8.8 $54.7 2012 2015 Sideris Pharmaceuticals Inc.....after a $32 million series A investment -- the MPM-led deal with Novartis AG for ... high altitude instant pot rice